Abstract-DNA-RNA hybridization was used to explore whether human neoplasias contain RNA molecules having sequence homologies to those of the RNA tumor viruses known to cause similar diseases in animals. The pattern of specific RNA's found in the human tumors showed a remarkable concordance with the predictions deducible from the animal systems. Thus, human breast cancer contains RNA homologous only tothat of the murine mammary tumor virus. Human leukemias, sarcomas, and Iymphomas (including Hodgkin's and Burkitt's Iymphomas) all contain RNA with sequence homology to the murine leukemia virus and not to murine mammary tumor virus RNA. Finally, as in the case of the mouse, none of the human tumors examined contains RNA in sequence to that of the avian myeloblastosis virus. The RNA detected in all of the human neoplasias was demonstrated tobe of high molecular weight (1 x 10 7 daltons) and encapsulated with a reverse transcriptase in particles having densities between 1·16 and 1·19 g/ml. Further, the RNA of thesehuman tumor particles was related in sequence to the murine viruses that cause the corresponding neoplasias in mice. Thus, four features diagnostic for the murine oncogenic viruses are satisfied by the particles found in the human cancers. Finally, it was shown by "recycling" experiments that the DN A from human lenkernie cells and from Iymphomatons tissue contained particle-related sequences that could not be detected in normal DNA. This finding was further substantiated by studies with identical twins in which it was shown that the lenkernie twin contained particle-related sequences that could not be detected in the leukocytes of bis identical healthy sibling. These findings are inconsistent with hypotheses that require chromosomal transmission in the germ Iine of complete copies of the information required to produce malignancy and the associated virus particles.
INTRODUCTION
One of the most striking characteristics of the cancer cell is that the malignant state is transmissible to its progeny. Over the years a number of explanations have been proposed to explain the cellular heritability of the cancer state. Some of these hypothetical mechanisms are listed in Table 1 , along with their predicted consequences for sequence changes detectable by the technique of nucleic acid hybridization. It should be noted that the methods generally employed to detect the heteroduplexes require stretches of complementary homology involving 50 or more hydrogen-bonded base pairs. Thus, for example, somatic mutations in a structural or regulatory gene are not likely to produce more than a few base changes and therefore could not be detected by molecular hybridization procedures. The same is true for chromosomal translocations or inversions since they would generate only minor sequence differences. The third mechanism of chromosomal imbalance resulting from the loss or extra duplication of one or more of the chromosomal complements can Iead only to the gain or loss of pre-existent sequences.
The fourth mechanism is a possibility that emerged from the study of the so-called "lysogenizing" or "transducing" phages. Here one has a phenomenon in which the virus inserts its genetic information into the genome of the host cell. If the virus involved is a DNA agent, there are no chemical problems posed and the mechanism of insertion of DNA into DNA via prior circularization is quite weil understood. 9 If, however, the virus involved is an RNA virus, then a mechanism is required for making a DNA transcript of the viral RNA, which can then be inserted into the DNA. This hypothesis then becomes formally identical to the early "provirus" hypothesis of Temin, 41 which ultimately led to the discovery of "reverse transcriptase" in the RNA tumor viruses. 4 • 42 The fifth hypothesis involves a heritable phenotypic PAAC VOL 47 NO 1-B ll modification unaccompanied by any change in the genetic information, quite analogaus to what is presumed to occur in cellular differentiation. Here we assume the preexistence of a silent malignant segment of genetic information that can undergo a self-reinforcing derepression. It is not too difficult to devisesuch mechanisms. For example, one could assume that when the repressor protein is free from the DNA, it can serve as a necessary functional subunit of an enzyme complex that synthesizes a molecule that can both stabilize the enzyme complex and also act as an inducer to derepress the malignant segment. Thus any intrinsic or extrinsic factor that dislodges the original repressor protein will initiate a chain of events that will ensure that the depression will be maintained and cytoplasmically transmitted. If the repressed malignant segment codes for an RNA tumor virus, the fifth hypothesis becomes equivalent to the "virogene-oncogene" hypothesis of Todaro and Huebner. 43 In what follows we describe experiments to decide amongst these alternatives for particular human neoplasias. There are several aspects of this type of analysis that merit explicit expression. The five mechanisms noted do not constitute an exhaustive Iist of a11 possibilities. · They do have the advantage of being sufficiently precise to permit the deduction of their consequences. Further, they are not mutually exclusive in either a general or a particular sense. Various forms of cancer in the same animal might be mediated by different mechanisms and sinu1arly for the same cancer in divergent animals. Finally, more than one of the mechanisms listed might be implicated in the occurrence of one and the same neoplasia. Thus, a11 one can experimentally hope to decide is whether one of the mechanisms is involved in a specific neoplasia in a particular animal. Support for one mechanism in a particular instance does not eliminate the others; it simply says they cannot be the sole cause.
The fourth mechanism is unique in making two s. Phenotyp1c
Sel f-reinforciilg derepression None of silent genes experimentally useful predictions. It is the only one that demands the active participation of a viral agent at some point of the carcinogenic process. It is also the only one that predicts the acquisition of new and viral-related information by the malignant cell. It is evident that any attempt to examine human cancer from this point of view must start with a search for evidence of viral agents in the human disease.
ANIMAL VIRAL ONCOLOGY
We had perhaps best begin by explicitly noting a bias stemming from our previous experiences with RNA viruses and our assessment of the information available on the relation between viruses and cancer. Both DNA and RNA tumor viruses have been identified as etiologic agents in laboratory experiments. However, we decided to concentrate our initial efforts on the RNA oncomaviruses, a choice made for two reasons. One isthat the RNA oncogenic agents predominate quantitatively in the animal systems studied. The second isthat it is the RNA tumor viruses that have been repeatedly demonstrated to cause tumors in their indigenous hosts. Thus, from . the viewpoint of the natural history of the disease, the RNA oncogenic viruses appeared to us as the more probable "natural" candidates for etiologic agents of cancer in the animal kingdom, including man.
Over the past 50 yr, animal viral oncology has amassed a considerable fund of information concerning the so-called B-type and C-type RNA tumor viruses. 15 These agents have been implicated in a variety of cancers in a wide spectrum of animals. In many instances, convincing evidence has been obtained by inoculation of purified viruses into susceptible animals in experiments that satisfy Koch's criteria for the identification of the causative agent of a particular disease.
Our working assumption was based on the improbability that cancer in man would have so different an etiological basis that the information provided by animal experiments would be irrelevant to the human disease. If this be the case, one might weil wonder why it has been so diffi.cult to provide acceptable evidence foraviral agent in human cancer. A plausible explanation emerges from an examination of the historical development of animal viral oncology. Forty to fifty years ago, it was as diffi.cult to identify viruses in animal tumors as it is today in the human neoplasias. The experimental picture changed dramatically as the result of a decision by geneticists that had a profound serendipic effect on the subsequent development of cancer research. A group of investigators, including Little, Strong, MacDowell and Furth, 15 developed highly inbred strains of mice, some of which were . characterized by a high frequency of various neoplasias, including mammary tumors, leukemias, etc. The intent was of course to mate these with low frequency strains and from the distribution of the characteristic cancer phenotype deduce the genetic factors underlying susceptibility and resistance to the disease. What occurred unexpectedly, however, was that in the course of developing the inbred stocks of high cancer frequency,a genetic background was inadvertently created permitting the tumor viruses to multiply to Ievels that made their identification inevitable. This, along with the introduction in 1951 by Gross of neonatal mice for virus assay, did much to open up the field of viral oncology.
Those who are concemed with human neoplasias are for the most part faced with the same diffi.culties encountered by the early animal oncologists before inbred strains were available. It follows that the detection of putative human viral agents requires more sensitive devices than those which suffi.ced to establish their presence in the inbred animal systems. In searching for such tools, we quite naturally tumed to molecular hybridization and the other methodologies developed by molecular biologists in the past several decades.
Our investigations evolved through a number of stages that are conveniently identified by the questions we posed sequentially for experimental resolution as our studies progressed.
(1) Do human neoplasias contain RNA molecules possessing detectable homology to the RNA of tumor viruses known to cause similar cancers in animals?
(2) If a positive outcome is obtained, do the RNA molecules identified in tumors possess the size and physical association with reverse transcriptase that characterize the RNA of the animal oncomaviruses?
(3) If such RNA exists in human tumors, is it encapsulated in a particle possessing the density and size of the RNA tumor viruses? (4) Does the RNA of human tumor particles possess homology to the RNA of the viruses causing the corresponding disease in animals?
(5) The virogene concept proposes that all animals prone to cancer carry in their germ line a complete copy of the information required to convert a cell from normal to malignant and for the production of tumor virus particles. Is this concept valid for randomly bred populations and in particular for the human disease?
TBE ANIMAL MODELS AS A POINT

OF DEPARTURE
Tobetter understand the biological rationale underlying the experiments to be described, it is useful to summarize briefly some of the salient features of the animal model systems used as a guide. Table 2 lists a representative group of animal viruses, including those actually employed to generate the molecular probes used. There are two avian viruses, myeloblastosis virus (AMV) and Rous sarcoma virus (RSV), that cause leukemias and sarcomas in chickens. In addition, we have the murine leukemia virus (MuL V) and murine sarcoma virus (MuS V) that induce similar diseases in mice, and finally the murine mammary tumor virus (MMTV), which is the unique etiologic agent for mammary tumors.
When these are examined for sequence homologies amongst their nucleic acids, a rather informative pattem emerges. It will be noted that the two chicken agents (AMV and RSV) have sequences in common but do not show detectable homology with any of the murine agents. Tuming to the murine viruses, we find that the nucleic acids of the leukemia, Iymphoma, and sarcoma agents show homology to one another but not to either of the two avian agents or to the mammary tumor virus. Finally, the mouse mammary tumor virus has a singular sequence homologous only to itself.
It is important to understand that a plus sign does not indicate identity but simply sufficient similarity to be detectable by the relaxed hybridization conditions used in these initial exploratory experiments. Similarly, a negative sign does not imply a complete absence of sequence homology but rather that none was detectable by the procedures employed.
If analogous virus particles are associated with the corresponding human diseases, certain predictions might be hazarded on the basis of the specifi.city pattems exhibited in Table 2 , and these may be listedas follows:
(1) In view of the Iack of homology between the avian and murine agents, it is unlikely that human agents, should they exist, would show homology to the avian group.
(2) It follows that the murine tumor viruses would represent a more hopeful source of the molecular probes to search for similar information in the analogous human cancers.
(3) If particles are found to be associated with human leukemias, sarcomas, and Iymphomas, their RNAs might show homology to one another and possibly to that of the murine leukemia virus.
(4) If RNA particles are identifi.ed in human breast cancer, these should not exhibit homology to the RNA of the virus-like particles associated with the human lymphoid neoplasias or to RLV RNA but might exhibit some homology to the RNA of the murine mammary tumor virus.
On the basis of availability and the considerations outlined above, it is clear why the murine agents were initially chosen for producing the necessary molecular probes to Iook for corresponding information in the human disease. Furthermore, the desire to monitor the biological consistency of our findings dictated that we examine in parallel the human neoplasias listed. This would permit us to quickly determine whether our findings in humans mirrored biologically what was known from the animal experimental models. For this purpose, from the onset, we focused our efforts on the lymphoid neoplasias and on breast cancer.
MOLECULAR HYBRIDIZATION WlTH RADIOACTIVE DNA PROBFS
To answer the first question posed on whether human tumors contain viral-related RNA's, we naturally turned to the use of DNA-RNA hybridization/ 8 which we designed some dozen years ago to answer questions of almost precisely this nature in the case of virus-infected bacteria. The method depends on the ability of any piece of single-stranded DNA to find its complementary RNA and form, under the proper conditions, a double-stranded hybrid structure. The reaction is highly specifi.c and has proved to be of considerable value in molecular biology over the past decade. , The radioactive DNA needed was synthesized by supplying detergent-disrupted virus preparations with magnesium and the four deoxyribosidetriphosphates required, one. of them being labeled with tritium. When the synthesis is terminated, the protein and the RNA present are eliminated and the residual radioactive DNA purifi.ed to completion. Each PH]DNA preparation must be rigorously monitored for the specificity of its hybridizability to its appropriate template. Thus, each probe is challenged with its homologous RNA as weil as with the other unrelated viral RNA's. Further, normal and cancer tissue RNA's from animal models were used to check the reliability of the hybridizations. Only if a probe demonstrated the required · specifi.city in these test hybridizations was it used for the subsequent experiments with human material.
There are certain features built into these exploratory experiments that are worthy of explicit mention. We of course did not know at the outset whether there would be any homology between the murine viruses and any putative human agents. At the time RL V and MMTV were among the few mammalian oncomaviruses available in adequate supply and we could only hope that they would have sufficient homology to be used for our purpose.
However, even if this hope were realized, it would hardly be likely that the homology would be extensive and therefore hybridization experiments bad to be carried out under conditions sufficiently relaxed to yield a reaction with a limited Ievel of homology. Further, the method of detection of hybrid structures would have to possess a low background noise Ievel so that weak positive reactions would be readily identified and distinguished from negative outcomes. Finally, the C,ot (concentration of nucleotides in mol/1 x time in sec) values of the annealing reactions were deliberately adjusted to be adequate for multiple (10 or more) rather than individual copies per cell. This was done in order to magnify any existent difference between normal and malignannissue. We were not initially concerned with determining whether normal cells could produce the same or related malignant messages at very low Ievels.
All of these considerations entered into the design of the detailed methodology used and are diagrammed in Fig.  1 . After monitaring for specificity, the purified viralspecific [ 3 H]DNA is mixed with cytoplasmic RNA prepared from a variety of human tumors and annealed under the conditions indicated. The hybridizations were always carried out with a vast excess of tumor RNA.
Since the viral-specific [ 3 H]DNA is small compared with the RNA, any complexes formed between them will behave physically more like RNA than like DNA. Such complexes are readily detected by isopycnic separation in equilibrium density gradients of Cs2S04• At the end of the centrifugation, the distribution of PH]DNA is examined across the gradient. Any uncomplexed DNA will remain at a density corresponding to about 1·45. DNA molecules that have annealed partially or completely to !arge RNA molecules will band at or near the density of RNA (p = 1·65).
The movement of the [ 3 H]DNA to the RNA region is then the signal that the probe used has found complementary sequences in the tumor RNA with which it is being challenged. It is important to emphasize that this test is essentially a qualitative one and does not measure how good the fit is in the duplex. A positive outcome says only that sufficient homology exists between the tritiated DNA probe and some RNA molecules in the tumor RNA sample to form a complex stable enough tobe detected by 3 H-DNA the test used. Once such structures are identified, the fidelity of the pairing can be exarnined by a temperaturerneil analysis. These more sophisticated examinations demand more hybrids than we could initially produce. It was therefore necessary to postpone these more informative experiments until more efficient probes became available. We understandably began by exploring those human malignancies for which there were suitable animal models and viruses. These included adenocarcinoma of the breast, 2 • 3 • 34 the leukemias/ 8 the sarcomas 23 and Iymphomas. 19 The leukemias examined encompassed both acute and chronic varieties of the lymphatic and myelogenous types. The human sarcomas studied included fibro, osteogenic, and liposarcomas. The series on Iymphomas contained Hodgkin's disease, Burkitt's tumors, lymphosarcomas, and reticulum cell sarcomas. Control adult and fetal tissues were always examined in parallel and these were invariably negative. In the case of breast cancer, the two benign diseases, fibroadenoma and fibrocystic disease, were also included and found to be negative. Table 3 summarizes in diagrammatic form the outcome of this survey of human neoplasias with the animal virus probes. The plus signs indicate that the corresponding [ 3 H]DNA formed complexes· with the indicated tumor RNAs and the negative signs that no such complexes were detected. The proportion of positives amongst those labeled plus in these earlier studies 2 • 3 • 18 " 19 " 23 • 34 ranged from about 67% for breast cancer to 92% for the leukemias. As our technology improved, so has our per cent positive amongst the neoplastic samples.
What is most noteworthy of the pattern exhibited in Table 3 is its concordance with the predictions deducible from the murine system. Thus, human breast cancer contains RNA homologaus only to that of the murine mammary tumor virus (MMTV). Human leukemias, sarcomas, and Iymphomas all contain RNA showing sufficient homology to that of the murine leukemia virus (RL V) to make a stable duplex. These lymphoid neoplasias contain no RNA homologaus to the MMTV RNA. Finally, none of the human tumors contains RNA detectably related tothat of the avian myeloblastosis virus (AMV). Recently Gallo and bis associatesu have confirmed the homology of leukemic RN A to that of RL V and in the process have shown even more relatedness to the The results of molecular hybridization between [ 3 H]DNA complementary to the various viral RN A's and pRNA preparations from the indicated neoplastic tissues. The plus sign indicates that hybridizations were positive and the negative sign, that none could be detected. '" RNA of a simian sarcoma virus. In summary, the specificity pattem of the unique RNA found in the. human neoplasias is in complete agreement with what has been described for the corresponding viral-induced malignancies in the mouse.
Needless to say, the existence of this remarkable concordance does not establish a viral etiology for these diseases in man. The next step requires performance of experiments designed to answer the second and third questions raised in the introduction, i.e. those relating to the size of the RNA being detected and whether it is associated with a reverse transcriptase in a particle possessing other features of complete or incomplete virus particles. We now turn our attention to the description of these techniques and their application to the analysis of human malignant tissue.
SIMULTANEOUS DETECTION TEST FOR REVERSE TRANSCRIPTASE AND WGH
MOLECULAR WEIGHT RNA
What we sought was a method of detecting the presence of particles similar to the RNA tumor viruses in human material that would be simple, sensitive, and sufficiently discriminating so that a positive outcome could be taken as an acceptable signal for the presence of a virus-like agent. To achieve this goal, we devised a test that depended on the simultaneaus detection of two diagnostic features of the animal RNA tumor viruses.
The oncomaviruses exhibit two identifying characteristics. They contain a large (1 x W daltons in molecular weight) single-stranded RNA molecule having a Sedimentation coefficient of 60-70S, often referred to as high molecular weight (HMW) RNA. They also have reverse transcriptase (4, 42) , an enzyme that can use the viral RNA as a template to make a complementary DNA copy. 37 The possibility of a concomitant test for both the enzyme and its template was suggested by our prior experience with RNA transcriptase. We found 38 that the growing RNA chain could be detected as a complex with its DNA template. Similarly, examination of the early reaction intermediate 31 " 37 of the reverse transcriptase reaction revealed that the initial DNA product was found complexed to the large 70S RNA template. These structures can be detected by the unusual position of the newly synthesized small tritiated DNA products in Cs2S04 density gradients, glycerol velocity gradients, and acrylamide gel electrophoresis. 8 The most informative assay is to subject the isotopically labeled product to sedimentation analysis prior to the removal of the RNA. If the labeled DNA product behaves as if it is a 70S molecule, and if it can be shown that it does so because it is complexed to a 70S RNA molecule, then evidence is provided for the presence of a reverse transcriptase using a 70S RNA template. One may then tentatively conclude that the material examined contains particles similar to the RNA tumor viruses.
It was on this basis that Schlom and Spiegelman 33 developed the simultaneaus detection test, which was used to demonstrate 35 the presence in human milk of particles containing 70S RNA and a reverse transcriptase. The textwas modified 16 tobe applicable to tumor tissue using the mouse mammary tumor as the experimental model. Figure 2 diagrams the procedure used. Tumor cells are first broken by the use of a Dounce homogenizer and the nuclei and large cell debris removed by low speed centrifugation. The supemate is subjected to trypsin digestion to inactivate any nucleolytic enzymes and the trypsin neutralized by trypsin inhibitor. The supemate is then centrifuged at a 150,000-g to yield a cytoplasmic pellet containing virus particles, if present. The resulting pellet is then banded isopycnically in a sucrose density gradient and the fraction between 1·16 and 1·19 g/ml collected and concentrated by centrifugation. This pellet is then treated with a nonionic detergent (0·1% of NP-40) to disrupt possible viral particles and used in an endogenaus reverse transcriptase reaction. It should be noted that detergent disruption is essential for a positive reaction, indicating that the enzyme and template are enclosed in a structure that must be opened up to make them accessible to the substrates. Actinomycin Dis always included (100-200 ,.,.g}ml) to inhibit DNA-instructed DNA synthesis. The product of the reaction with its RNA template is freed of protein and then analyzed in a glycerol velocity gradient to determine the Sedimentation coefficient of the [ 3 H]DNA as weil as in a Cs2S04 equilibriilm gradient to determine its density. The presence of particles encapsulating 70S RNA and reverse transcriptase will be indicated by the appearance of a peak of newly synthesized DNA traveling at a speed corresponding to a 70S RNA molecule. That its apparent large size is due to its being complexed to a 70S RNA molecule can be readily verified by subjecting the purified nucleic acid to ribonuclease prior to velocity examination and this should result in the disappearance of the "70S" [ 
The simultaneaus detection test was first applied to human breast cancer ' and Fig. 3 exemplifies a positive reaction with material obtained from a malignant adenocarcinoma and treated as outlined in Fig. 2 . Here we see the 70S DNA complex observed with the P-100 fraction and it is evident that this complex is an RNA-dependent one since prior treatment with ribonuclease eliminates the [ 3 H]DNA from the 70S region of the velocity gradient. In this series, 38 adenocarcinomas and ten nonmalignant controls were examined in this manner. It was found that 79% of the malignant samples were positive for the simultaneaus detection reaction and all of the control samples from normal and benign tissue were negative. 3 . Effect of ribonuclease on the detection of the highmolecular-weight RNA-rHJDNA complex. Breast tumor tissue (adenocarcinoma 756-5-72) was processed as described in Fig. 2 . The viral pellet (P-100) was suspended in 0·01 M Tris-HCI (pH 8· 3) and divided into two equal parts. A standard RNA-instructed DNA polymerase reaction was performed on one part of the P-100 fraction; after incubation for 15 min at 37°, the nucleic acid complex was extracted with phenol-cresol and was sized on a 30--10% linear glycerol gradient (e---e). After disruption with detergent, the other half of the P -100 fraction was incubated in the presence of RNase A (50 ~g/ml) and RNase T, (50 ~g/ml) for 15 min at 25°. A standard RNA-instructed DNA polymerase reaction was then performed (0---0). ' The data obtained therefore indicated that one can, with a high probability, find in human breast cancers particulate elements that encapsulate RNA-instructed DNA polymerase and a 70S RNA. It was of obvious interest to see whether this reaction peaked in the density region characteristic of an RNA tumor virus. To this end, aliquots of pellet fractions, which gave positive simultaneaus detection tests, were first subjected to sucrose equilibrium centrifugation in a linear gradient of 25-50% sucrose. The gradient was then divided into 10 equal fractions, which were diluted to 15% sucrose and spun at 100,000 g for 1 hr to pellet any particles present. Bach of these pellets was then tested to determine the distribution in the density gradient of the reaction that yields a 70S RNA-instructed DNA-synthesizing activity .lt is clearfrom the results shown in Fig. 4 that particles possessing the reverse transcriptase activity and its 70S RNA template localize at a density between 1·16 and 1·19 g/ml, the density characteristic of the oncogenic viruses. ..
.. Fraetion number Fig. 4 . Density of 70S RNA and RNA-instructed DNA polymerase activity in extracts of human mammary tumors by sucrose gradient centrifugation. A P-100 pellet was prepared from human mamma.rY tumor. The pellet was suspended in Tris-NaCI-EDTA buffer and layered on a linear gradient of 50--25% sUcrose in the same buffer and spun at 25,000 rpm in a SW27 (Spinco) rotor at 4• for 195 min. The gradientwas dripped from below and ten equal fractions were collected; fractions were then diluted with TrisNaCI-EDTA buffer to a sucrose concentration of less than 15%. Each fraction was then spun at 100,000 g. The amount of 70S [ 3 H]DNA synthesized by an endogenaus RNA-instructed DNA polymerase was determined by glycerol velocity centrifugation.
APPLICATION OF THE SIMULTANEOUS DETECriON TFST TO THE LEVKEMIAS
In the study of the leukemias, 5 peripheral leukocytes were prepared from the buffy coats of both lenkernie and nonlenkernie control patients. Cells were disrupted and fractionated as described in Fig. 2 . Representative experiments examining the effects of ribonuclease treatment of the product and omission of one of the deoxytriphosphates during the reaction are shown in Fig.  5 . We see the telltale70S peaks of DNA synthesized by the pellet fractions from the leukocytes of patients with acute lymphoblastic and acute myelogenous leukemias. The elimination of the complex by prior treatment with ribonuclease ( Fig. 5A) shows that the tritiated DNA is indeed complexed to a 70S RNA molecule. Further, the omission of dATP (Fig. 5.B) Ieads to a failure to form the 70S complex, a result expected if the reaction is in fact leading to the synthesis of a proper heteropolymer. In . 50 p.g/ml actinomycin D were added to inhibit DNA-instructed DNA synthesis. After incubation at 37°C for 15 min, the reaction was adjusted to 0·2 M NaCI and 1% SDS, and deproteinized by phenol-cresol extraction. The aqueous phase was layered on a 10 to 30% gradient of glycerol in TNE buffer (0·01M, Tris-HCI, pH 8·3, 0·1M, NaCI, 0·003M, EDTA) and centrifuged in a SW-41 rotor Spinco at 40,000rpm for 180 min at 2•c. Fractions were collected from below and assayed for TCA-precipitable radioactivity. In this, as in all sedimentation analysis, 70S RNA of the avian myeloblastosis viruswas used as a marker.
(A) One aliquot of product was run on the gradient as a control and the other was pretreated with 20 p.g of RNase 1 (Worthington) for 15 min at 37"C prior to Sedimentation analysis.
(B) Reactions with and without dATP.' similar experiments, it was shown that omission of either dCTP or dGTP also resulted in. the absence of the 70S RNA-fH]DNA complex, all of which argues against nontemplated end addition reactions. In some cases leukemic cells were obtained in amounts adequate to permit a more complete characterization of the product. Hybridization of the human product to the appropriate viral RNA's provides the most revealing information since it tests sequence relatedness to known oncogenic agents. We summarize in Table 4 the results of examining the peripheralleukocytes of 23 patients, all in the active phases of their disease, including both acute and chronic leukemias. Of the 23 leukemic patients examined, 22 showed clear evidence that their peripheral leukocytes contained particles mediating a reaction leading to the appearance of endogenously synthesized DNA in the 70S region of a glycerol gradient. Nine of these were tested for ribonuclease sensitivity and in a11 cases the complexes were destroyed. In nine others, the DNA was recovered from the complex and annealed to RLV RNA and to either MMTV RNA or AMV RNA. In all nine, hybridizations occurred with RLV RNA and not to either of the unrelated MMTV RNA or AMV RNA. In four patients, enough DNA complex was formed to permit a complete characterization of the product. In all four, the DNA complexes were destroyed by ribonuclease and the purified DNA hybridized uniquely to RLV RNA.
It is noteworthy that positive outcomes were observed in more than 95% of the leukemic patients whether they were acute or chronic, lymphoblastic or myelogenous. Thus, despite their disparate clinical pictures and differing cellular pathologies, these various types of leukemias have similar, though probably not identical, virus-related information.
In contrast with these results are those obtained with a control series of eighteen white blood samples from nonleukemic patients. These included nine with elevated white blood cell counts (in the range of 25,000/mm 3 ) due to a variety of disorders, including polycythemia vera. None of these exhibited evidence of an RNA-DNA complex that was ribonuclease-sensitive and contained DNA that hybridized specifically with RLV RNA. Thus, none of the eighteen nonleukemic individuals exhibited evidence of the specific 70S RNA-directed DNA synthesis found in virtually all of the leukemic patients examined.
IMPLICATIONS OF SIMULTANEOUS DETECTION TESTS ON HUMAN BREAST CANCER AND TBE LEUKEMIAS
The experiments we have just summarized on human breast cancer and the leukemias were designed to probe further the etiological significance of our exploratory investigations, 2 • 18 which identified in these neoplasias RNA homologaus to those of the corresponding murine oncornaviruses. The data obtained with the simultaneaus detection test established that at least a portion of the tumor-specific virus-related RNA we were detecting was a 70S RNA template physically associated with a reverse transcriptase in a particle possessing a density between 1·16 and 1·19 g/tril, three of the diagnostic features of the animal RNA tumor viruses. Further, the DNA synthesized in the particles from both classes of neoplasias hybridized uniquely to the RNA of the corresponding oncornavirus. Note that this last result is complementary to and completes the logic of our experimental approach. We started out by using animal tumor viruses to generate eHJDNA probesthat were used to find related RNA in human neoplastic tissue. We concluded by using analogous human particles to generate [ 3 H]DNA probes, which were then used to determine sequence relatedness to the RNA.of the relevant oncomaviruses. None of the human probes hybridized to the avian viral RNA. The probe generated by the particles from human breast cancer was homologous only to the RNA of mouse mammary tumor virus, whereas the human leukemic probe was related in sequence only to RL V RNA, the murine leukemic agent. The biologically logical consistency of these results adds further weight to their relevance to the human disease.
ON THE PROBLEM OF GERM-UNE TRANSMISSION OF VIRAL INFORMATION
We now come to grips with the virogene-oncogene concept, 43 which derives from animal experiments and argues that all animals prone to cancer contain in their germ line at least one complete copy of the information necessary and sufficient to convert a cell from normal to malignant and produce the correspondidg tumor virus. This hypo.thesis presumes that the malignant segment usually remains silent and that its activation by intrinsic or extrinsic factors Ieads to the appearance of virus and the onset of cancer.
There are various ways of testing the validity of the virogene-oncogene hypothesis, but the pathways differ in the technical complexities entailed. One approach commonly used attempts to answer the question: Does every normal cell contain at least one complete copy of the required viral-related malignant information? The methodologies used included the techniques of genetics, However, for a variety of reasons, none of these gave, or could give, conclusive answers. Genetic experiments do not readily distinguish between susceptibility genes and actual viral information. Further, even if genetic data succeeded in identifying some structural viral genes, it would still be necessary to establish that all the viral genes are represented in the genome. Attempts to settle the question by demonstrating that every cell of an animal can be chemically induced to produce viruses have thus far, for obvious reasons, not been tried. The best that has been achieved along these lines is to show that cloned cells do respond positively. However, the proportion of clonable cells is small and clonability may weil be a signal for prior infection with a tumor virus. Finally, the quantitative limitations of molecular hybridization make it almost impossible to provide definitive proof that each cell contains one complete viral copy in its DNA. Although it is not very difficult to show that 90% of the information is present, it is the last 10% that constitutes the insurmountable barrier and 10% of 3 x 1Q6 daltons amounts to a far from trivial 3 x 10 5 daltons, the equivalent of about one gene.
A useful way to obviate these technical difficulties is to invert the problem. Instead of asking whether one complete copy exists in normal cells, the question can be phrased in the following terms: Does the DNA of a malignant cell contain viral-related sequences that are not found in the DNA of its normal counterpart? Phrasing the issue in this manner Ieads to the design of experiments that avoid the uncertainties generated by the demonstrated fact that many indigenous RNA tumor viruses share, completely or partially, some sequences with the normal DNA of their natural hosts. 32 The crucial point is of course whether all of the viral sequences are to be found in normal DNA. The approach we adopted requires removal of those viral sequences that are contained in non-neoplastic DNA by exhaustive hybridization of the viral probe to normal DNA in vast excess. Any unhybridized residue can then be used to determine whether malignant DNA contains viral-related sequences not detectable in normal tissue.
We first investigated this question in the case of the human leukemias 6 and the strategy, as diagrammed in Fig.  6 (a, b) , may be outlined in the following steps:
( (e) If viral-related sequences are detected in both, remove those found in normal leukocytes by exhaustive hybridization to normal DNA; and (f) Test the residue for specific hybridizability to leukemic DNA.
In carrying out the recycling and test hydridizations, it is imperative that conditions be chosen to account for the possibility that the leukemia-specific sequences are present in only one copy per genome, a possibility which is in fact realized. 6 To this purpose, the concentration in moles per Iiter (C0) of DNA and the time (t in sec) of annealing is adjusted to C0t values of 10,000, which are adequate to locate unique sequences.
A typical outcome of hybridizing such recycled tritiated DNA to normal and leukemic DNA is shown in Fig. 7 . It is evident that no complexes stable at temperatures above 88°C are formed with normal DNA. On the other band, 57% of the recycled [lH]DNA probe forms well-paired duplexes with leukemic DNA. A series of such experiments was performed with particle-generated [ 3 H]DNA and nuclear DNA obtained from 8 untreated patients with either acute or chronic myelogenous leukemia. In every case (Table 5) , the [lH]DNA, after being subjected to exhaustive annealing to normal DNA, yielded a residue that forms stable duplexes only with leukemic DNA, in agreement with the experiment in Fig. 7 .
In estimating the implication of this result, it must be recalled that the leukemia-specific sequences found 6 in leukemic cells are present as nonreiterated copies per genome. This was established by the C0t values (concentration of nucleotides x time) required to detect them. The sensitivity used to examine normal cells for the leukemia-specific sequences was such that 1/50th of an equivalent of that found in leukemic cells would have been readily detected. Consequently, one may conclude that the vast majority of normal cells do not contain this particular stretch of malignant information and it cannot therefore be represented in the germ line of nonleukemic individuals. We have already noted that, like the leukemias, Hodgkin's and Burkitt's Iymphomas have particles containing reverse transcriptase and a 70S RNA template related in sequence to that of RLV. It was of obvious interest to determine whether the Iymphomas also parallel the leukemias in possessing a unique sequence not detectable in normal tissue. If they do, one can in addition ascertain whether the sequences found in Hodgkin's and Figure 8 shows the outcome of challenging recycled Hodgkin's disease PHJDNA with nuclear DNA from normal spieen, Hodgkin's disease spieen, and from Burkitt's Iymphoma. Few, if any, stable duplexes are formed with normal DNA. Note, however, that although the probe was made with Hodgkin's disease particles, the PHJDNA hybridized to Burkitt's Iymphoma nuclear DNA virtually as weil as it complexed to DNA from Hodgkin's spieen. The converse is also true, as may be seen from Table 6 , which summarizes the results of our findings in the recycled [ 3 H]DNA challenged with nuclear DNA from normal and malignant tissues. 26 Again, normal DNA is 20 . 44 and the non-neoplastic infectious mononucleoses/'· 30 it is revealing to note from Table 6 that the leukocyte DNA of patients with infectious mononucleosis was devoid of the Burkitt's sequences detected by the recycled [ 3 H)DNA probe, indicating that these latter sequences are specific for neoplastic tissues. The fact that the particle-related sequences in Hodgkin's and Burkitt's tumors are related to each other adds further weight to this conclusion. Finally, the observation that cells carrying multiple copies of the DNA of the Epstein-Barr virus do not complex with recycled [lH]DNA probes from either Hodgkin's or Burkitt's particles proves that these particle sequences have no relation to the DNA of the Epstein-Barr virus.
EVJDENCE FROM STUDIFS OF IDENTICAL TWINS
Although the comparison of leukemic patients with normals suggests that healthy individuals do not contain the leukemia-specific sequences, the data do not rule out the possibility that those who do come down with the disease do so because they in fact inherit the required information in their germ line. One way to resolve this issue is to study the situation in identical twins. Since identical twins are monozygous, i.e. derive their genomes from the same fertilized egg, any chromosomally transmitted information must be present in both. It bad already been shown by Goh and bis colleagues ' 2 ·' 3 in the case of chronic myelogenous leukemia that only the leukemic member of each of two identical twin pairs contained the marker Philadelphia chromosome. It was of obvious interest to examine this situation for the leukernia-speeifie sequenees. If the lenkernie member of the pair eontains the particle-related DNA sequenees, and does so beeause he inherited them through his germ line, then these same sequenees must be found in the leukoeyte DNA of his healthy sibling. To perform the experiment, it was neeessary to loeate identieal twins with eompletely eonvineing evidenee for monozygosity and where only one of them was leukernie. Further, the twins had tobe of adult age sinee at least a unit of whole blood is required to provide enough lenkoeyte DNA to earry out the required hybridization. Two sets of identieal twins satisfying all these requirements were found and an experiment sirnilar to the one outlined above was performed with eaeh pair. 7 In eaeh instanee, particles eontaining the reverse transeriptase and 70S RNA were again isolated from the leukoeytes of the lenkernie members and used to generate the [lH]DNA endogenously. The [lH]DNA was purified and sequenees shared with normal DNA removed by exhaustive hybridization· in the presenee of a vast exeess of normal DNA from random bealthy blood donors. Tbis was then followed by hydroxyapatite ehromatography to separate paired from unpaired [ 3 H]DNA. It is important to emphasize that in the reeyeling step, the normal DNA used eame from the leukoeytes of healthy, random blood donors and not from the normal twin. To have used the latter would have obviously eonfused the issue. The residue of the tritiated DNA that did not pair with the normal DNA was then used to test for the presenee of a sequenee in the leukoeyte DNA of the patient and that of bis healthy sibling.
The results obtained with the two sets of twins are deseribed in Fig. 9 and it is evident that the same situation holds between the members of the twin pairs as was observed in the eomparison of unrelated lenkernie patients and random normals (Fig. 7 and Table 5 ). The lenkernie twin eontains particle-related sequenees that eannot be deteeted in the lenkoeytes of his healthy sibling.
The faet that we eould establisb a sequenee differenee between identieal twins implies that the additional information found in the DNA of the lenkernie members was inserted after zygote formation. This finding argues against tbe applieability of the virogene hypothesis to this disease sinee it would demand that the leukernia-speeifie sequenees found in the DNA of the individual with the disease must surely also exist in the genome of bis The annealing reaction mixtures contained 20 Au,o units of cellular DNA, 0·004 pmol of ['H]DNA, and 15 ~mol NaH PO. (pH 7·2) in a final vol of 0·01 ml. The reaction was brought to 98•c for 60 sec and 0·04 mmol of NaCI was added. The reaction mixture was then incubated at 60° x 50 hr. The reaction was stopped by the addition of 1 ml of 0·05 M NaH PO. (pH 6·8). The sample was then passed over a column of hydroxyapatite of 20-ml-bed vol at 60•c. The column was washed with 40 ml of 0·15 M NaH PO. (pH 6·8) at 600C, 800C, 88•c and 95•c. Fractions of 4 ml were collected, the Au,o of each fraction was read, and the DNA was precipitated with 2 p,g/ml of carrier yeast RN A and 10% trichloroacetic acid. The precipitate was collected on Millipore filters, which were dried and counted. In all cases, greater than 80% of the nuclear DNA reannealed. A background count of 8 cpm was subtracted in all instances. 7 identical twin. These results are also inconsistent with the possibility that individuals who succumb to leukemia do so because they inherit the complete viral genome.
PRESENT STATUS AND FUTURE PROSPECTS
Wehave summarized here experiments indicating that human breast cancers and mesenchymal tumors contain particulate entities possessing several of the diagnostic features of the RNA tumor viruses. In addition to size and density, these include the presence of a 70S RNA molecule encapsulated in an internal core with an enzyme, reverse transcriptase, that can employ the RNA as a template to make a DNA copy. Further, the particulate RNA's of the leukemias, Iymphomas and sarcomas are related in sequence to each other. The partiCulate RNA of human breast cancer possesses a unique sequence unrelated to those found in the mesenchymal tumors.
The fact that the human particles possess sequence homology to similar agents known to cause the corresponding neoplasias in mice encourages the hope that they arerelevant to the human disease. However, despite the considerable progress that can be recorded, no definitive proof exists at the present writing that the virus-like particles found in the human neoplasias are either viruses or etiologic agents of the cancers in which they are found. Proof will ultimately come if it proves possible to produce the relevant malignancy in a susceptible animal by injection of particles purified from the human tumors. It should be noted, however, that we have known of the mouse mammary tumor virus for more than 35 yr and no one has succeeded in producing mammary tumors with this agent in any animal, other than the mouse.
Under the circumstances, it would seem prudent not to wait for the definitive experiment with the human particles but rather to proceed with attempts at further exploration of their significance and possible clinical usefulness.
One important step forward would be accomplished by establishing particle-produ'cing human tumor cells in short, or preferably, long-term culture. That this advance is in fact on its way is suggested by a number of recent reports. Thus, McGrath et a/. 29 describe a human breast carcinoma cellline that may be a source of breast cancer particles. Kotler et a/. 22 have succeeded in inducing the release of virus-like particles from human leukemic cells by arginine starvation. Mak and bis coileagues 12 • 13 have been setting up short-term cultures of leukemic hone marrow aspirates in a conditioned medium and finding particles in the tissue culture fluid. Finally, and most recently, Gailagher and Gallo 10 have reported what appears to be a highly productive line established from a patient with acute myelogenous leukemia. The particles produced appear to have some antigenic relatedness to the simian sarcoma agent. 36 All attempts to establish productive long-term cultures are always exposed to the all pervasive danger of contamination with known animal oncornaviruses. Because of this, any evidence that the agent produced is either identical or even similar to a known animal oncornavirus has been accepted as sufficient evidence to condemn the culture and its particle as irrelevant to the human disease. It is important to recognize, however, that this is not a fool-proof argument. For example, it could weil be true that a virus found initially in a non-human primate may have originally come from a human source. It is also not safe to conclude that an agent is human if it cannot be identified by either base sequence or antigenic properties with a known animal virus. Quite· clearly, until our catalogue of all animal tumor viruses is complete, this line of reasoning has no compeiling logical basis.
Is there at present any criterion that can be usefully used to decide whether a given tissue culture virus is in fact of possible relevance to human cancer? There is one possible answer to this question and it depends on the presence of unique viral-related sequences in the DNA of malignant cells. I/ the DNA of the original tumor from which the culture was derived contains sequences found in the particles produced by the tissue culture, then contamination during cultivation can be eliminated. If this condition is satisfied, the particle cannot be dismissed as an irrelevant contaminant no matter what its relatedness to known animal oncornaviruses.
There is one further comment that can be made about the presence of unique sequences in malignant DNA. Their existence is clearly not consistent with any mechanism that does not involve the insertion of viral-related sequences into the DNA of a malignant ceil. Again this does not mean that other mechanisms are not operating, but these cannot, in the face of this evidence, be the sole mechanism. Further, the identical twin data require the postzygotic insertion into the genome of the viral information, a process known to occur with RNA tumor viruses in animal cells bothin tissue cultures 14 and in whole animals 40 under laboratory conditions.
It is evident that these findings suggest more optimistic pathways for the control of these diseases than would be available if the total information were already present in the genome. The data imply that in at least some cancers we may not be forced to master the control of our own genes in order to cope with these neoplasias. Finaily, the existence of the leukemia-specific sequences can provide the clinician with a hitherto unsuspected parameter that could potentiaily be a useful adjunct in diagnosis and in monitoring therapy. Future efforts should attempt to extend these unique sequence differences to proteins for which they may weil code. This would provide unique proteins as signals for the presence of the corresponding neoplasias and could open up the possibility of immunological approaches for both the diagnosis and the treatment of these diseases.
